Validation of a New Method to Measure Cardiac Output: Comparison With Thermodilution
Continuous Thermodilution, Transpulmonary Thermodilution and Pressure Recording Analytical Method for Cardiac Output Measurement During Hemodynamic Instability: a Prospective Clinical Study
1 other identifier
observational
36
1 country
1
Brief Summary
Many mini-invasive devices to monitor cardiac output (CO) have been introduced and among them the Pressure Recording Analytical Method (PRAM). The aim of this study is to assess the agreement of PRAM with the intermittent transpulmonary thermodilution (ThD) and continuous pulmonary ThD in measuring CO in hemodynamically unstable patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 26, 2013
CompletedFirst Posted
Study publicly available on registry
March 7, 2013
CompletedMarch 7, 2013
March 1, 2013
8 months
February 26, 2013
March 6, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Blant-Altman test and coefficient of error of Cardiac Output measured with PRAM towards that measured with thermodilution
Agreement between Cardiac Output measured with PRAM and cardiac output measured with thermodilution (both pulmonary and transpulmonary thermodilution) was determined by the Bland-Altman method. The precision of the measurements was given by the limits of agreement (LoA) (±1.96SD) of the mean difference of the methods compared. Upper and lower LoA were calculated as the bias ± 1.96SD. The percentage error was calculated as the LoA of the bias divided by the mean CO from two methods compared. Thirty per cent was considered an a priori criterion of interchangeability.
Study Period: 9 months
Study Arms (2)
critically ill patients
patients admitted to the medical-surgical ICU
post-cardiac surgical patients
patients admitted to the post-cardiac surgical ICU
Eligibility Criteria
hemodynamic instability
You may qualify if:
- Hemodynamic instability in:
- septic shock
- pneumonia
- polytrauma
- chronic obstructive pulmonary disease
- heart failure
- post operative cardiosurgical patients
You may not qualify if:
- Atrial fibrillation
- Pacemaker or implantable cardiac defibrillator
- Aortic or mitral valve disease
- Intra-aortic balloon pump
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Ospedali Riuniti Ancona
Ancona, Ancona, 60126, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Abele Donati, MD
UPollitecnicaDM
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 26, 2013
First Posted
March 7, 2013
Study Start
August 1, 2011
Primary Completion
April 1, 2012
Study Completion
May 1, 2012
Last Updated
March 7, 2013
Record last verified: 2013-03